Roble Belko & Company Inc lifted its holdings in shares of iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) by 15.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,113 shares of the company’s stock after purchasing an additional 976 shares during the period. Roble Belko & Company Inc’s holdings in iShares iBonds Dec 2032 Term Corporate ETF were worth $178,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Ameriprise Financial Inc. increased its holdings in iShares iBonds Dec 2032 Term Corporate ETF by 1,327.4% in the 4th quarter. Ameriprise Financial Inc. now owns 598,242 shares of the company’s stock worth $14,705,000 after acquiring an additional 556,331 shares during the last quarter. Captrust Financial Advisors increased its holdings in iShares iBonds Dec 2032 Term Corporate ETF by 8.8% in the 4th quarter. Captrust Financial Advisors now owns 33,387 shares of the company’s stock worth $821,000 after acquiring an additional 2,704 shares during the last quarter. United Capital Financial Advisors LLC increased its holdings in iShares iBonds Dec 2032 Term Corporate ETF by 6.9% in the 4th quarter. United Capital Financial Advisors LLC now owns 9,202 shares of the company’s stock worth $226,000 after acquiring an additional 596 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in iShares iBonds Dec 2032 Term Corporate ETF by 3.9% in the 1st quarter. Janney Montgomery Scott LLC now owns 298,906 shares of the company’s stock worth $7,470,000 after acquiring an additional 11,330 shares during the last quarter. Finally, Cary Street Partners Financial LLC purchased a new stake in iShares iBonds Dec 2032 Term Corporate ETF in the 4th quarter worth about $322,000.
iShares iBonds Dec 2032 Term Corporate ETF Price Performance
Shares of IBDX opened at $25.28 on Wednesday. The business has a 50-day moving average of $25.00 and a 200 day moving average of $24.83. iShares iBonds Dec 2032 Term Corporate ETF has a fifty-two week low of $24.05 and a fifty-two week high of $25.89.
iShares iBonds Dec 2032 Term Corporate ETF Company Profile
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- Retail Stocks Investing, Explained
- Should Investors Lock Arms With Buffett and Dive Into POOL Stock?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2
- Which Wall Street Analysts are the Most Accurate?
- Analysts Are Upgrading These 3 Massive AI Stocks After Earnings
Want to see what other hedge funds are holding IBDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report).
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.